Litcius/Paper detail

Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting

Bahar Saberzadeh-Ardestani, Jeremy Jones, Robert R. McWilliams, David Tougeron, Þorvarður R. Hálfdánarson, Rosine Guimbaud, Joleen M. Hubbard, Clémence Flecchia, Qian Shi, Emily Alouani, Mohamad Bassam Sonbol, Jonathan Ticku, Zhaohui Jin, Julien Taı̈eb, Frank A. Sinicrope

2023European Journal of Cancer26 citationsDOI

Topics & Concepts

MedicineOncologyInternal medicineColorectal cancerResponse Evaluation Criteria in Solid TumorsMetastasisCohortProportional hazards modelProgressive diseaseRetrospective cohort studyCancerImmune checkpointProgression-free survivalImmunotherapyDiseaseChemotherapyCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting | Litcius